ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CNTA Centessa Pharmaceuticals PLC

17.98
-0.21 (-1.15%)
23 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue -3.14M00006.85M00
Operating Income -52.17M-41.6M-48.88M-47.02M-44.76M-30.63M-36.09M-43.98M
Pre Tax Income -54.02M-43.84M-50.04M-48.94M-41.47M-35.69M-37.57M-43.11M
Net Income -53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -52.17M-39.26M-50.22M-48.55M-41.89M-36.06M-37.63M-43.83M
EBITDA -52.23M-41.47M-48.79M-46.78M-44.52M-30.38M-35.85M-43.74M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 006.85M
Operating Income -374.08M-212.26M-171.28M
Pre Tax Income -380.96M-216.95M-176.14M
Net Income -381.07M-216.21M-151.09M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -4.235-2.28-1.53
EBIT -374.08M-209.92M-176.71M
EBITDA -374.05M-212.13M-170.47M

Your Recent History

Delayed Upgrade Clock